Cite
HARVARD Citation
Inoue, A. et al. (n.d.). ANGI-2 Identification and functions of CD44 as a predictor for bevacizumab-resistant glioblastoma to optimally treat the tumor with bevacizumab. Neuro-oncology advances. p. vi2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Inoue, A. et al. (n.d.). ANGI-2 Identification and functions of CD44 as a predictor for bevacizumab-resistant glioblastoma to optimally treat the tumor with bevacizumab. Neuro-oncology advances. p. vi2. [Online].